What we do
Gold standard medication adherence solutions
Our intelligent packaging solutions combined with secure HIPAA cloud-based analytics are the gold standard in medication adherence management, with over a million of our medication adherence devices deployed.
Our medication adherence solutions are user-friendly, patient centric, and NFC mobile-connected (iPhone and Android). ECMs record when medication is removed and stores the real-time data on-board the IoT-connected NFC-certified smart package.
Our ECM solutions drives IMP traceability and logistics efficiency by tracking temperature and product integrity, location/diversion, and medication adherence.
How we do it
Patient centric interconnectivity is the key to increasing the efficiency of clinical trials and clinical care.
Scalable, robust, accurate smart bottles and intelligent blisters are widely deployed. User-friendly NFC mobile functionality combined with secure cloud-based analytics have established our ECMs as the gold standard in clinical trials management and remote patient adherence monitoring.
Why medication adherence matters
Patients are only 50 to 65 percent adherent, and this reduces a clinical trial’s statistical power – the ability to detect a treatment effect if one exists. IMC’s intelligent packaging solutions allow for the early detection of non-adherence and correction through self-discovery, education and motivational counselling.
What it delivers
ECMs record when medication is removed and stores the real-time data on-board the smart package.
The fast and advanced CertiScan® Cloud Adherence Data collection platform stores real-time objective adherence data for remote patient monitoring (RPM). Electronic acquisition and analysis of remote patient data gives care givers a timely view of medication adherence.
IMC’s biostatistics experts have modelled the relationship between statistical power, sample size and medication adherence, and demonstrated that for each percentage medication adherence is increased, a clinical trial’s sample size can be reduced by two percent while holding statistical power constant.
Adjusting outcome data for medication non-adherence increases a clinical trial’s statistical power and provides dramatic ROI. Calculate your ROI.